Cargando…
Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice
BACKGROUND & AIMS: Alcoholic liver disease (ALD) remains a major cause of morbidity and mortality, with no Food and Drug Administration–approved therapy. Chronic alcohol consumption causes a pro-oxidant environment and increases hepatic lipid peroxidation, with acrolein being the most reactive/t...
Autores principales: | Chen, Wei-Yang, Zhang, Jingwen, Ghare, Smita, Barve, Shirish, McClain, Craig, Joshi-Barve, Swati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042858/ https://www.ncbi.nlm.nih.gov/pubmed/28119953 http://dx.doi.org/10.1016/j.jcmgh.2016.05.010 |
Ejemplares similares
-
Tributyrin Mitigates Ethanol-Induced Lysine Acetylation of Histone-H3 and p65-NFκB Downregulating CCL2 Expression and Consequent Liver Inflammation and Injury
por: Ghare, Smita S., et al.
Publicado: (2023) -
Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV
por: Moghe, Akshata, et al.
Publicado: (2017) -
Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice
por: Singhal, Richa, et al.
Publicado: (2021) -
Tributyrin Inhibits Ethanol-Induced Epigenetic Repression of CPT-1A and Attenuates Hepatic Steatosis and Injury
por: Donde, Hridgandh, et al.
Publicado: (2019) -
Focus on the Liver: Alcohol Use, Highly Active Antiretroviral Therapy, and Liver Disease In HIV-Infected Patients
por: Barve, Shirish, et al.
Publicado: (2010)